Back to Results
First PageMeta Content
Protease inhibitors / Non-nucleoside reverse transcriptase inhibitors / Pfizer / Amides / Reverse-transcriptase inhibitor / Antiretroviral drug / Delavirdine / HIV drug resistance / Efavirenz / Chemistry / Organic chemistry / HIV/AIDS


JOURNAL OF CLINICAL MICROBIOLOGY, May 2004, p. 2353–[removed]/$08.00⫹0 DOI: [removed]JCM[removed]–[removed]Vol. 42, No. 5 Weak Agreement between Antivirogram and PhenoSense Assays in
Add to Reading List

Document Date: 2004-05-07 21:56:41

Open Document

File Size: 37,69 KB

Share Result on Facebook

City

South San Francisco / Pleasanton / San Francisco / Atlanta / Durham / /

Company

Antivirogram / Pearson / ABC / Roche Molecular Systems Inc. / PhenoSense Assays / ViroLogic Inc. / Lee Bacheler Virco Lab Inc. / /

Country

Belgium / /

Currency

USD / /

/

Event

Business Partnership / /

Facility

Microbiology University of Washington Seattle / B. Larder / B. A. Larder / /

/

MedicalCondition

HIV / /

Organization

Calif. Lee Bacheler Virco Lab / Microbiology University of Washington Seattle / Stanford / Kai Wang Ram Samudrala John Mittler* Department / Centers for Disease Control and Prevention / /

Person

C. Van Den Eynde / V / A. Van Cauwenberge / M. Van Houtte / Qari Walid Heneine / V. Van Gerwen / G. A. Winslow / Washington Seattle / Kai Wang Ram Samudrala John Mittler / /

/

Position

D. J. / EDITOR / /

Product

efavirenz / zidovudine / nevirapine / abacavir / lamivudine / didanosine / stavudine / /

ProvinceOrState

North Carolina / California / Georgia / /

PublishedMedium

JOURNAL OF CLINICAL MICROBIOLOGY / /

SocialTag